Macular pucker and cataract treated with phacoemulsification and IOL implantation combined with small-gauge pars plana vitrectomy: a comparison of outcomes with and without femtosecond laser assistance.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2025-05-01 eCollection Date: 2025-01-01 DOI:10.3389/fmed.2025.1497776
Howard Wen-Haur Chao, Cheng-Kuo Cheng, Shiow-Wen Liou, Hsiao-Ming Chao
{"title":"Macular pucker and cataract treated with phacoemulsification and IOL implantation combined with small-gauge pars plana vitrectomy: a comparison of outcomes with and without femtosecond laser assistance.","authors":"Howard Wen-Haur Chao, Cheng-Kuo Cheng, Shiow-Wen Liou, Hsiao-Ming Chao","doi":"10.3389/fmed.2025.1497776","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Age-related cataracts and macular pucker are increasingly common. Standard treatment combines phacoemulsification, IOL implantation and small gauge vitrectomy. Recent advancements and acceptance of femtosecond laser (FSL) assistance in cataract surgery have improved precision and outcomes. However, evidence regarding the efficacy and safety of FSL-assisted phacovitrectomy, particularly in Oriental patient populations with distinct anatomical and genetic characteristics, remain limited. This study aims to address this critical gap by comparing the safety and post-operative outcomes of 23- or 25-gauge phacovitrectomy for stage 3 macular pucker and medium density cataract with versus without FSL-assistance (FSLA), in an Oriental patient cohort.</p><p><strong>Methods: </strong>Patients with stage 3 macular pucker and medium-density cataract were recruited and divided into two age-matched groups: group 1 (<i>n</i> = 13) underwent conventional phacovitrectomy without FSLA, and Group 2 (<i>n</i> = 13) underwent phacovitrectomy with FSLA. Evaluations included pre- and postoperative best-corrected visual acuity (BCVA; Snellen E and LogMAR), cataract surgical time, phacoemulsification energy cost, corneal wavefront data, endothelial cell density (ECD), and surgical complications.</p><p><strong>Results: </strong>Significant improvements in postoperative visual acuity were observed in both groups (<i>P</i> < 0.05), with Group 2 (FSLA) demonstrating superior outcomes (0.48 ± 0.05/-0.45 ± 0.06; Snellen E/logMAR) compared to Group 1 (0.26 ± 0.07/-0.66 ± 0.15; Snellen E/logMAR). FSLA significantly reduced surgical duration (429.46 s vs. 740.00 s) and cumulative dissipated energy (CDE; 18.90 ± 1.59 vs. 25.24 ± 1.42) without significantly altering higher-order aberrations (0.24 to 0.22 μm). Although ECD decreased postoperatively in both groups, FSLA phacovitrectomy resulted in significantly less endothelial cell loss (227.77 ± 46.85 cells/mm<sup>2</sup>) compared to conventional phacovitrectomy (389.15 ± 47.87 cells/mm<sup>2</sup>). No serious complications were reported in either group.</p><p><strong>Conclusion: </strong>FSLA phacovitrectomy presents a safe and more efficient alternative over traditional procedures for Oriental patients with medium density nuclear cataract patients with stage 3 macular pucker. Through enhanced IOL centration, shortened surgical times and decreased ECD loss, FSLA led to superior postoperative visual outcomes compared to traditional phacovitrectomy. This study addresses a critical gap in the literature by providing evidence for the benefits of FSLA in Oriental populations, offering valuable insights into its applicability in patients with distinct anatomical variations.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1497776"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078321/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1497776","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Age-related cataracts and macular pucker are increasingly common. Standard treatment combines phacoemulsification, IOL implantation and small gauge vitrectomy. Recent advancements and acceptance of femtosecond laser (FSL) assistance in cataract surgery have improved precision and outcomes. However, evidence regarding the efficacy and safety of FSL-assisted phacovitrectomy, particularly in Oriental patient populations with distinct anatomical and genetic characteristics, remain limited. This study aims to address this critical gap by comparing the safety and post-operative outcomes of 23- or 25-gauge phacovitrectomy for stage 3 macular pucker and medium density cataract with versus without FSL-assistance (FSLA), in an Oriental patient cohort.

Methods: Patients with stage 3 macular pucker and medium-density cataract were recruited and divided into two age-matched groups: group 1 (n = 13) underwent conventional phacovitrectomy without FSLA, and Group 2 (n = 13) underwent phacovitrectomy with FSLA. Evaluations included pre- and postoperative best-corrected visual acuity (BCVA; Snellen E and LogMAR), cataract surgical time, phacoemulsification energy cost, corneal wavefront data, endothelial cell density (ECD), and surgical complications.

Results: Significant improvements in postoperative visual acuity were observed in both groups (P < 0.05), with Group 2 (FSLA) demonstrating superior outcomes (0.48 ± 0.05/-0.45 ± 0.06; Snellen E/logMAR) compared to Group 1 (0.26 ± 0.07/-0.66 ± 0.15; Snellen E/logMAR). FSLA significantly reduced surgical duration (429.46 s vs. 740.00 s) and cumulative dissipated energy (CDE; 18.90 ± 1.59 vs. 25.24 ± 1.42) without significantly altering higher-order aberrations (0.24 to 0.22 μm). Although ECD decreased postoperatively in both groups, FSLA phacovitrectomy resulted in significantly less endothelial cell loss (227.77 ± 46.85 cells/mm2) compared to conventional phacovitrectomy (389.15 ± 47.87 cells/mm2). No serious complications were reported in either group.

Conclusion: FSLA phacovitrectomy presents a safe and more efficient alternative over traditional procedures for Oriental patients with medium density nuclear cataract patients with stage 3 macular pucker. Through enhanced IOL centration, shortened surgical times and decreased ECD loss, FSLA led to superior postoperative visual outcomes compared to traditional phacovitrectomy. This study addresses a critical gap in the literature by providing evidence for the benefits of FSLA in Oriental populations, offering valuable insights into its applicability in patients with distinct anatomical variations.

超声乳化人工晶状体植入术联合小尺寸玻璃体切割治疗黄斑皱状白内障:飞秒激光辅助与非飞秒激光辅助的疗效比较。
目的:年龄相关性白内障和黄斑皱越来越常见。标准治疗包括超声乳化、人工晶状体植入术和小尺寸玻璃体切除术。飞秒激光(FSL)辅助白内障手术的最新进展和接受度提高了精度和结果。然而,关于fsl辅助晶状体切除术的有效性和安全性的证据,特别是在具有独特解剖和遗传特征的东方患者群体中,仍然有限。本研究旨在通过比较在东方患者队列中使用与不使用FSLA辅助(FSLA)的23或25号玻璃体切除术治疗3期黄斑折叠和中密度白内障的安全性和术后结果来解决这一关键差距。方法:招募3期黄斑皱缩合并中密度白内障患者,分为年龄匹配的两组:1组(n = 13)行常规玻璃体切除术,不加FSLA; 2组(n = 13)行玻璃体切除术,不加FSLA。评估包括术前和术后最佳矫正视力(BCVA;Snellen E和LogMAR)、白内障手术时间、超声乳化术能量消耗、角膜波前数据、内皮细胞密度(ECD)和手术并发症。结果:两组患者术后视力均有显著改善(P < 0.05),其中2组(FSLA)疗效更好(0.48±0.05/-0.45±0.06;Snellen E/logMAR)与1组比较(0.26±0.07/-0.66±0.15;Snellen E / logMAR)。FSLA显著缩短手术时间(429.46 s vs. 740.00 s)和累积耗散能量(CDE;18.90±1.59 vs. 25.24±1.42),高阶像差(0.24 ~ 0.22 μm)无明显变化。尽管两组患者术后ECD均有所下降,但与常规玻璃体切除术(389.15±47.87细胞/mm2)相比,FSLA玻璃体切除术导致的内皮细胞损失(227.77±46.85细胞/mm2)明显减少。两组均无严重并发症。结论:FSLA晶状体切除术是治疗中密度核性白内障伴3期黄斑皱的一种安全有效的方法。通过增强IOL的集中,缩短手术时间和减少ECD损失,与传统的晶状体切除术相比,FSLA获得了更好的术后视力结果。本研究填补了文献中的一个关键空白,为FSLA在东方人群中的益处提供了证据,为其在具有不同解剖变异的患者中的适用性提供了有价值的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信